Search research articles
Contact Us
Filters
Showing results (161-170 of 207) with videos related to
Page
of 21
Sort By:
Plos One
|
June 11, 2025
Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH)
Pedro Cahn, Luis Barreto, Maria Ines Figueroa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 21, 2012
Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE Trials
Calvin J Cohen, Jean-Michel Molina, Pedro Cahn, et al.
Journal of the International AIDS Society
|
July 14, 2015
Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean
Gabriela Carriquiry, Valeria Fink, John Robert Koethe, et al.
Scientific Reports
|
February 15, 2019
Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa
María Paula Caruso, Juliana Falivene, María Pía Holgado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 28, 2025
Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study
Maria Ines Figueroa, Carlos Brites, Diego Cecchini, et al.
European Journal of Immunology
|
June 6, 2015
HIV-TB coinfection impairs CD8(+) T-cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses
Guadalupe V Suarez, Matías T Angerami, María B Vecchione, et al.
The New England Journal of Medicine
|
March 27, 2020
Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection
Michael Kozal, Judith Aberg, Gilles Pialoux, et al.
The Journal of Infectious Diseases
|
August 23, 2003
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial
Ulrik Bak Dragsted, Jan Gerstoft, Court Pedersen, et al.
Plos One
|
September 16, 2014
Use of third line antiretroviral therapy in Latin America
Carina Cesar, Bryan E Shepherd, Cathy A Jenkins, et al.
Journal of the International AIDS Society
|
August 12, 2011
Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters
M Eugenia Socías, Omar Sued, Natalia Laufer, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 207) with videos related to
Sort By:
Page
of 21
Plos One
|
June 11, 2025
Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH)
Pedro Cahn, Luis Barreto, Maria Ines Figueroa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 21, 2012
Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE Trials
Calvin J Cohen, Jean-Michel Molina, Pedro Cahn, et al.
Journal of the International AIDS Society
|
July 14, 2015
Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean
Gabriela Carriquiry, Valeria Fink, John Robert Koethe, et al.
Scientific Reports
|
February 15, 2019
Impact of HIV-ART on the restoration of Th17 and Treg cells in blood and female genital mucosa
María Paula Caruso, Juliana Falivene, María Pía Holgado, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 28, 2025
Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study
Maria Ines Figueroa, Carlos Brites, Diego Cecchini, et al.
European Journal of Immunology
|
June 6, 2015
HIV-TB coinfection impairs CD8(+) T-cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses
Guadalupe V Suarez, Matías T Angerami, María B Vecchione, et al.
The New England Journal of Medicine
|
March 27, 2020
Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection
Michael Kozal, Judith Aberg, Gilles Pialoux, et al.
The Journal of Infectious Diseases
|
August 23, 2003
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial
Ulrik Bak Dragsted, Jan Gerstoft, Court Pedersen, et al.
Plos One
|
September 16, 2014
Use of third line antiretroviral therapy in Latin America
Carina Cesar, Bryan E Shepherd, Cathy A Jenkins, et al.
Journal of the International AIDS Society
|
August 12, 2011
Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters
M Eugenia Socías, Omar Sued, Natalia Laufer, et al.
Page
of 21